Quantitative association between a newly identified molecular variant in the endothelin-2 gene and human essential hypertension

Journal of Hypertension

Volumn 17, Issue 9, 1999, Pages 1281-1287

  Sharma, Pankaj ^a,b   Hingorani, Aroon ^a   Haiyan, Jia ^a   Hopper, Ruth ^a   Brown, Morris J ^a  

^a UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^b ADDENBROOKE S HOSPITAL   (United Kingdom)

Author keywords

Association study; Endothelin 2; Essential hypertension; Functional variant; Gene; Genetic study; Genetics; Molecular biology

Indexed keywords

ENDOTHELIN 2;

ADULT; AGED; ALCOHOL CONSUMPTION; ALLELE; ARTICLE; BODY MASS; CAUCASIAN; CONTROLLED STUDY; DIASTOLIC BLOOD PRESSURE; DISEASE SEVERITY; ESSENTIAL HYPERTENSION; FEMALE; GENE FREQUENCY; GENE LINKAGE DISEQUILIBRIUM; GENE LOCUS; GENE SEQUENCE; GENETIC ASSOCIATION; GENOTYPE; HAPLOTYPE; HETEROZYGOTE; HOMOZYGOTE; HUMAN; MAJOR CLINICAL STUDY; MALE; MOLECULAR GENETICS; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; REGRESSION ANALYSIS; SINGLE STRAND CONFORMATION POLYMORPHISM; SMOKING HABIT; STATISTICAL ANALYSIS;

EID: 0032708725     PISSN: 02636352     EISSN: None     Source Type: Journal    
DOI: 10.1097/00004872-199917090-00007     Document Type: Article

References (23)

1. 1 Jeunemaitre X, Soubrier F, Kotelevtsev YV, Lifton RP, Williams GS, Charru A, et al. Molecular basis of human hypertension: role of angiotensinogen. Cell 1992; 71:169-180.
2. 2 Sharma P. Genes for ischaemic stroke: strategies for their detection. J Hypertens 1996; 14:277-285.
3. 3 Stevens PA, Brown MJ. Genetic variability of the ET-1 and the ET(A) receptor genes in essential hypertension. J Cardiovasc Pharmacol 1995; 26:S9-S12.
4. 4 Levin ER. Endothelins. N Engl J Med 1995; 333:356-363.
5. 5 Komuro I, Kurihara H, Sugiyama T, Takaku F, Yazaki Y. Endothelin stimulates c-fos and c-myc expression and proliferation of vascular smooth muscle cells. FEBS Lett 1988; 238:249-252.
6. 6 Yokokawa K, Tahara H, Kohno M, Murakawa K, Yasunari K, Nakagawa K, et al. Hypertension associated with endothelin-secreting malignant hemangio-endothelioma. Ann Int Med 1991; 114:213-215.
7. 7 Luscher TF. The endothelium in hypertension: bystander, target or mediator? J Hypertens 1994; 12:S105-S116.
8. 8 Paul M, Rettig R, Zintz M, Kreutz R, Ganten D. Characterisation of transgenic rats carrying the human endothelin-II gene (abstract). Hypertension 1993; 22:P11.
9. 9 Kurihara Y, Kurihara H, Suzuki H, Kodama T, Maemura K, Nagai R, et al. Elevated blood pressure and craniofacial abnormalities in mice deficient in endothelin-1. Nature 1994; 368:703-710.
10. 10 Hosoda K, Hammer RE, Richardson JA, Baynash AG, Cheung JC, Giaid A, et al. Targeted and natural (Piebald-Lethal) mutations of endothelin-β receptor gene produce megacolon associated with spotted coat color in mice. Cell 1994; 79:1267-1276.
11. 11 Liefeldt L, Bocker W, Schonfelder G, Zintz M, Paul M. Regulation of the endothelin system in transgenic rats expressing the human endothelin-2 gene. J Cardiovasc Pharmacol 1995; 26:S32-S33.
12. 12 Hocher B, Liefeldt L, ThoneReineke C, Orzechowski HD, Distler A, Bauer C, et al. Characterization of the renal phenotype of transgenic rats expressing the human endothelin-2 gene. Hypertension 1996; 28:196-201.
13. 13 Sharma P, Lu F, Rut A, Brown MJ. Structure of human endothelial-2 gene and demonstration of common expression in human right atrial tissue. Biochem Biophys Res Commun 1998; 245:709-712.
14. 14 Prosser J. Detecting single-base mutations. TIBTECH 1995; 11:239-246.
15. 15 Ohlstein EH, Douglas SA. Endothelin-1 modulates vascular smooth muscle structure and vasomotion: implications in cardiovascular pathology. Drug Dev Res 1993; 29:108-128.
16. 16 Deng AY, Dene H, Pravenec M, Rapp JP. Genetic mapping of two new blood pressure quantitative trait loci in the rat by genotyping endothelin system genes. J Clin Invest 1994; 93:2701-2709.
17. 17 Risch N, Zhang H. Extreme discordant sib pairs for mapping quantitative trait loci in humans. Science 1995; 268:1584-1589.
18. 18 Bennett ST, Lucassen AM, Gough SCL, Powell EE, Undlien DE, Pritchard LE, et al. Susceptibility to human type 1 diabetes at IDDM2 is determined by tandem repeat variation at the insulin gene minisatellite locus. Nature Genet 1995; 9:284-292.
19. 19 Shaw G, Kamen R. A conserved AU sequence from the 3′ untranslated region of GM-CSF mRNA mediates selective mRNA degradation. Cell 1986; 46:659-667.
20. + antiporter as a candidate gene in human essential hypertension. Hypertension 1991; 17:8-14.
21. 21 Cambien F, Poirier O, Lecerf L, Evans A, Cambou J, Arveiler D, et al. Deletion polymorphism in the gene for angiotensin-converting enzyme is a potent risk factor for myocardial infarction. Nature 1992; 359:641-644.
22. 22 Lindpaintner K, Pfeffer MA, Kreutz R, Stampfer MJ, Grodstein F, Buring J, et al. A prospective evaluation of an angiotensin-converting-enzyme gene polymorphism and the risk of ischemic heart disease. N Engl J Med 1995; 332:706-711.
23. 23 Arinami T, Ishikawa M, Inoue A, Yanagisawa M, Masaki T, Yoshida MC, et al. Chromosomal assignments of the human endothelin family genes: the endothelin-1 gene to 6p23-p24, the endothelin-2 gene to 1p34, and the endothetin-3 gene to 20q13.2-q13.3. Am J Hum Genet 1991; 48:990-996.